Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2020

Primary Completion Date

September 7, 2021

Study Completion Date

December 1, 2021

Conditions

Confirmed Coronavirus Disease

Interventions

DRUG

Ruconest

Patients will be randomized to Ruconest or Standard of Care

Trial Locations (4)

Virtua Marlton Hospital, Marlton

Virtua Memorial Hospital, Mount Holly

The Valley Hospital, Ridgewood

Virtua Voorhees Hospital, Voorhees Township